Zobrazeno 1 - 10
of 189
pro vyhledávání: '"Mehmet, Sinan Dal"'
Autor:
Tahir Darcın, Istemi Serın, Mehmet Can Ugur, Omer Ekinci, İpek Yönal Hindilerden, Seval Akpınar, Tuba Hacıbekiroglu, Sinan Demircioğlu, Emine Gulturk, Murat Albayrak, İsmet Aydoğdu, Mehmet Sinan Dal, Mehmet Hilmi Doğu, Sinem Namdaroğlu, Ali Dogan, Meliha Nalçacı, Burhan Turgut, Semih Başcı, Fevzi Altuntaş
Publikováno v:
Hitit Medical Journal, Vol 6, Iss 2, Pp 186-192 (2024)
Objective: We present data of patients with relapsed/ refractory T cell lymphomas treated with brentuximab vedotin (BV) in real-world practice. Material and Method: This study is an observational, multi-center, retrospective study. The data of patien
Externí odkaz:
https://doaj.org/article/9ca01e30518240fc9f0619b73350c36a
Autor:
Atakan Tekinalp, Ayfer Gedük, Aydan Akdeniz, Esra Terzi Demirsoy, Vildan Gürsoy, Müzeyyen Aslaner Ak, Metin Bağcı, Sema Seçilmiş, Fatma Keklik Karadağ, Ayşe Oruç Uysal, Ali Doğan, Sinan Demircioğlu, Haşim Atakan Erol, Ceyda Aslan, Fahir Özkalemkaş, Şehmus Ertop, Mehmet Dağlı, Mehmet Sinan Dal, Güray Saydam, Mustafa Merter, Cihan Ural, Özcan Çeneli
Publikováno v:
Turkish Journal of Hematology, Vol 40, Iss 4, Pp 242-250 (2023)
Objective: This study aimed to evaluate patients with relapsed/ refractory multiple myeloma (RRMM) who underwent daratumumab (DARA) therapy. Materials and Methods: This multicenter retrospective study included 134 patients who underwent at least two
Externí odkaz:
https://doaj.org/article/4debcdb81b4a4484a3947f563fe04669
Autor:
Ersin Bozan, Tahir Darçın, Samet Yaman, Tuğçe Nur Yiğenoğlu, Merih Kızıl Çakar, Mehmet Sinan Dal, Fevzi Altuntaş
Publikováno v:
Journal of Medical Case Reports, Vol 17, Iss 1, Pp 1-3 (2023)
Abstract Background Erdheim Chester disease (ECD) is a rare disease with multisystemic involvement in the group of non-langerhans cell histiocytosis. Although nearly 100 years have passed since its definition, the number of cases reported all over th
Externí odkaz:
https://doaj.org/article/daad40402a4d4c65adff4829467f0739
Autor:
İstemi Serin, Mehmet Hilmi Doğu, Ömer Ekinci, Gülsüm Akgün Çağlıyan, Abdulkadir Baştürk, Merih Reis Aras, Sinan Demircioğlu, Burhan Turgut, Mustafa Merter, Sibel Kabukçu Hacıoğlu, Metin Bağcı, Murat Albayrak, Serdal Korkmaz, Mehmet Ali Erkurt, Mehmet Sinan Dal, Fadime Ersoy Dursun, Anıl Tombak, İsmet Aydoğdu, Turgay Ulaş, Fevzi Altuntaş
Publikováno v:
İstanbul Medical Journal, Vol 24, Iss 2, Pp 120-125 (2023)
Introduction:Ruxolitinib is a small -molecule inhibitor of the JAK1/2 pathway. This study aimed to reveal the results and side-effect profile of the use of ruxolitinib as a treatment option in polycythemia vera (PV).Methods:A total of 34 patients wit
Externí odkaz:
https://doaj.org/article/2f9813f1062246cfa7c5bb2a592ed5f8
Autor:
Özgür Mehtap, Tayfur Toptas, Mehmet Sinan Dal, Güner Hayri Özsan, Nigün Sayinalp, Güray Saydam, Mehmet Ali Uçar, Hakki Onur Kirgizlar, Ozan Salim, Atakan Tekinalp, Fahir Özkalemkaş, Funda Pepedil Tanrikulu, Olga Meltem Akay, Emrah Kiliçaslan, Semra Paydas, Sinem Civriz, Mehmet Yilmaz, Volkan Karakuş, Fatma Geçgel, Tahir Darçin, Elçin Erdoğan, Erkin Çinar, Fatma Keklik Karadağ, Ünal Ataş, Vildan Gürsoy, Salih Sertaç Durusoy, Elif Birtaş Ateşoğlu, Anil Tombak, Nurhilal Büyükkurt, Muhit Özcan, Fevzi Altuntaş, Ahmet Burhan Ferhanoğlu
Publikováno v:
HemaSphere, Vol 7, p e566791c (2023)
Externí odkaz:
https://doaj.org/article/e9b3c75689fe4673b443fbabb3a75f21
Autor:
Semih Başcı, Ersin Bozan, Samet Yaman, Bahar Uncu Ulu, Mehmet Bakırtaş, Tuğçe Nur Yiğenoğlu, Ali Kılınç, Nurgül Özcan, Mehmet Sinan Dal, Merih Kızıl Çakar, Fevzi Altuntaş
Publikováno v:
Asian Journal of Transfusion Science, Vol 18, Iss 1, Pp 21-26 (2022)
INTRODUCTION: Autologous stem cell transplantation (ASCT) is a well-established consolidation treatment for many hematologic cancers which delivers prolonged survival. A subset of patients’ adequate stem cell harvest is not achievable with a solita
Externí odkaz:
https://doaj.org/article/04ff07c0364a487b91ff284d0e8e1c59
Autor:
Dicle Iskender, Mehmet Obut, Ayse Keles, Ozgur Arat, Ozge Yucel Celik, Dilara Sarikaya, Mehmet Kaya, Mehmet Sinan Dal, Can Tekin Iskender
Publikováno v:
Medicine Science, Vol 11, Iss 1, Pp 148-53 (2022)
To evaluate diagnostic performance of Neutrophil/lymphocyte ratio (NLR), Platelet to lymphocyte ratio (PLR) and platelecrit in the first and third trimester in preeclampsia. This was a single center case control study conducted between January 2015 a
Externí odkaz:
https://doaj.org/article/64e0dd4892f146a486c284f1e22dae07
Autor:
Samet Yaman, Semih Basci, Gökhan Turan, Bahar Uncu Ulu, Tugçe Nur Yigenoglu, Taha Bahsi, Haktan Bagis Erdem, Mehmet Sinan Dal, Merih Kizil Çakar, Fevzi Altuntas
Publikováno v:
Iraqi Journal of Hematology, Vol 11, Iss 2, Pp 130-133 (2022)
BACKGROUND: Polycythemia is a common reason for patients' admissions. With the introduction of COVID-19, face masks reached very common usage in the population. Masks may cause some degree of hypoxia that may result in high hemoglobin in healthy indi
Externí odkaz:
https://doaj.org/article/044163731e0a4e45ad3c0d24ad6691b4
Autor:
Mehmet Bakirtas, Tuğçe Nur Yiğenoğlu, Semih Başci, Bahar Uncu Ulu, Samet Yaman, Merih Kizil Çakar, Mehmet Sinan Dal, Fevzi Altuntaş
Publikováno v:
Iraqi Journal of Hematology, Vol 11, Iss 1, Pp 7-12 (2022)
BACKGROUND: Febrile neutropenia (FN) is a serious problem, especially in hematologic malignancies, and can cause high mortality rates and it occurs in 10%–20% of patients with lymphoma. The aim of this research is to assess the risk factors for FN,
Externí odkaz:
https://doaj.org/article/27f425be4cab436487fd6e377a4594a4
Autor:
Bahar UNCU ULU, Derya ŞAHİN, Tuğçe Nur YİĞENOĞLU, Merih KIZIL ÇAKAR, Mehmet Sinan DAL, Fevzi ALTUNTAŞ
Publikováno v:
Namık Kemal Tıp Dergisi, Vol 9, Iss 2, Pp 207-212 (2021)
Aim:Outcome for most patients with peripheral T cell lymphomas (PTCLs) is poor, with low response rates and short durations of remission. We aim to analyze the outcome of PTCL patients who underwent autologous stem cell transplantation (ASCT) at our
Externí odkaz:
https://doaj.org/article/c6dba53227324b1f9423e3c590824231